Sankei Chemical Co., Ltd. (FKSE:4995)
Japan
· Delayed Price · Currency is JPY 1,644.00
-56.00 (-3.29%)
At close: Mar 9, 2026
Sankei Chemical Income Statement
Financials in millions JPY. Fiscal year is December - November.
Millions JPY. Fiscal year is Dec - Nov.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | 2020 - 2016 |
| Revenue | 6,444 | 6,052 | 5,998 | 7,242 | 7,032 | Upgrade
|
| Revenue Growth (YoY) | 6.48% | 0.90% | -17.18% | 2.99% | 4.78% | Upgrade
|
| Cost of Revenue | 4,839 | 4,684 | 4,665 | 5,672 | 5,212 | Upgrade
|
| Gross Profit | 1,605 | 1,368 | 1,333 | 1,570 | 1,820 | Upgrade
|
| Selling, General & Admin | 1,142 | 1,099 | 1,111 | 1,119 | 1,131 | Upgrade
|
| Research & Development | 282 | 224 | 233 | 218 | 183 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 113 | Upgrade
|
| Operating Expenses | 1,424 | 1,323 | 1,344 | 1,337 | 1,427 | Upgrade
|
| Operating Income | 181 | 45 | -11 | 233 | 393 | Upgrade
|
| Interest Expense | -24 | -21 | -17 | -14 | -13 | Upgrade
|
| Interest & Investment Income | 12 | 16 | 14 | 13 | 9 | Upgrade
|
| Earnings From Equity Investments | 87 | 66 | 30 | 31 | 40 | Upgrade
|
| Other Non Operating Income (Expenses) | 23 | 31 | 21 | 37 | 23 | Upgrade
|
| EBT Excluding Unusual Items | 279 | 137 | 37 | 300 | 452 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 16 | 16 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1 | 64 | - | - | - | Upgrade
|
| Asset Writedown | -1 | - | -1 | -2 | -9 | Upgrade
|
| Other Unusual Items | -66 | - | 1 | - | - | Upgrade
|
| Pretax Income | 213 | 217 | 53 | 298 | 443 | Upgrade
|
| Income Tax Expense | 29 | 51 | 10 | 80 | 120 | Upgrade
|
| Earnings From Continuing Operations | 184 | 166 | 43 | 218 | 323 | Upgrade
|
| Minority Interest in Earnings | -3 | -34 | -7 | -6 | -10 | Upgrade
|
| Net Income | 181 | 132 | 36 | 212 | 313 | Upgrade
|
| Net Income to Common | 181 | 132 | 36 | 212 | 313 | Upgrade
|
| Net Income Growth | 37.12% | 266.67% | -83.02% | -32.27% | 114.38% | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | -1.24% | -4.00% | -1.35% | -0.02% | -0.02% | Upgrade
|
| EPS (Basic) | 201.95 | 145.44 | 38.08 | 221.23 | 326.57 | Upgrade
|
| EPS (Diluted) | 201.95 | 145.44 | 38.08 | 221.23 | 326.57 | Upgrade
|
| EPS Growth | 38.85% | 281.95% | -82.79% | -32.26% | 114.42% | Upgrade
|
| Free Cash Flow | 357 | 387 | -462 | -270 | 521 | Upgrade
|
| Free Cash Flow Per Share | 398.32 | 426.42 | -488.69 | -281.76 | 543.59 | Upgrade
|
| Dividend Per Share | - | 25.000 | 25.000 | 30.000 | 25.000 | Upgrade
|
| Dividend Growth | - | - | -16.67% | 20.00% | 31.58% | Upgrade
|
| Gross Margin | 24.91% | 22.60% | 22.22% | 21.68% | 25.88% | Upgrade
|
| Operating Margin | 2.81% | 0.74% | -0.18% | 3.22% | 5.59% | Upgrade
|
| Profit Margin | 2.81% | 2.18% | 0.60% | 2.93% | 4.45% | Upgrade
|
| Free Cash Flow Margin | 5.54% | 6.40% | -7.70% | -3.73% | 7.41% | Upgrade
|
| EBITDA | 315 | 171 | 107 | 336 | 500 | Upgrade
|
| EBITDA Margin | 4.89% | 2.83% | 1.78% | 4.64% | 7.11% | Upgrade
|
| D&A For EBITDA | 134 | 126 | 118 | 103 | 107 | Upgrade
|
| EBIT | 181 | 45 | -11 | 233 | 393 | Upgrade
|
| EBIT Margin | 2.81% | 0.74% | -0.18% | 3.22% | 5.59% | Upgrade
|
| Effective Tax Rate | 13.61% | 23.50% | 18.87% | 26.85% | 27.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.